Close Modal


Archive: July 2020

Twitter Poll (July 22, 2020)

Polyomavirus Nephropathy, Banff Class 3, Twitter Poll, Arkana Laboratories
ANSWER: C The answer is C, Polyomavirus Nephropathy, Banff Class 3. The Banff Working Group Classification was created by Nickeleit et al. to provide a classification scheme to aid communication, better standardize reporting of polyomavirus nephropathy, and provide a way for better comparative analysis of cases going forward. The classification is broken into three classes, Banff Class 1-3. This case highlights an example of a Polyomavirus Nephropathy, Banff Class 3 with a pvl score of 3 and ci (fibrosis) score of 2. Based on this score, the findings of the Banff working group showed that approximately 50% of these patients...

Communication in the Time of Covid

communication in times of covid, arkana voices, arkana laboratories, human resources
I have seen many variations of a particular meme but they all say basically the same thing “Oh how I miss 'precedented' times…they were the best!” But here we are, in very UNprecedented times, that have brought unique challenges to the world of human resources. The passage of the FFCRA and CARES acts in response to the novel coronavirus have brought with them a slew of changes, both immediate and evolving. Many agencies such as the Department of Labor, OSHA, ERISA and the CDC have issued their guidance and interpretations of such hastily enacted legislation and the ever-shifting understanding of...

Chronic Cyclosporine Toxicity in Pediatric Nephrotic Syndrome

Pediatric Nephrotic Syndrome, childhood nephrotic syndrome, CSA, CNI, juxtaglomerular apparatus
This biopsy is from a 9-year-old boy who developed pediatric nephrotic syndrome in the first year of life and has been maintained on cyclosporine (CSA) due to frequent relapses. He had not had a biopsy before and was clinically on remission, considering switching to rituximab. The biopsy was performed to assess chronic changes and the presence of histologic signs of chronic calcineurin inhibitor (CNI) toxicity CNI toxicity. His serum creatinine was 0.6 mg/dL. He was also on lisinopril for proteinuria control. He was not hypertensive. The biopsy contained a total of 61 glomeruli, four of which were globally sclerotic. No...

The MYMP Has Been Caught!

Dr. Best, MYMP, Detection of SARS-CoV-2, publication, arkana laboratories, arkana visualized
Dr. Best has caught the MYMP! Along with Dr. Larsen, Dr. Sharma, Dr. Caza, and Dr. Kuperman, Dr. Best recently published a paper covering the detection of SARS-CoV-2 in formalin-fixed paraffin. Read the paper: Detection of SARS-CoV-2 in Formalin-Fixed Paraffin-Embedded Tissue Sections Using Commercially Available Reagents Who will catch the MYMP next?

Diagnose This (July 13, 2020)

Fabry's disease, myelosomes, zebra bodies, X linked disease
What is your diagnosis?     ​ ​   ​   ​ ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​ ​   ​ ​   ​ ​   ​ ​     ​   ​   ​ ​  ...

Twitter Poll (July 8, 2020)

Twitter Poll, Deficiency of adenine phosphoribosyltransferase , APRT, Arkana Laboratories
ANSWER: D Renal oxalosis is a progressive tubulointerstitial disease which can be primary or secondary in nature. Specifically, secondary causes can be due to increased ingestion or absorption of sources of oxalate, decreased excretion, and certain vitamin imbalances. Oxalosis secondary to ingestion can occur with ingestion of oxalate containing foods such as rhubarb, spinach, peanuts, tea, starfruit, and ethylene glycol poisoning, among others. Increased absorption of oxalate containing substances occurs in maladaptive states such as after gastric/intestinal bypass surgery, prolonged antibiotic use, Crohn's disease, pancreatic insufficiency, and in short bowel syndrome. Other causes of oxalosis would include hypervitaminosis C, vitamin...

Diagnose This (July 6, 2020)

light chain deposition disease, Diagnose This, Arkana Laboratories, renal pathology
What is your diagnosis based on the EM image provided?     ​ ​   ​   ​ ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​   ​ ​   ​ ​   ​ ​   ​ ​     ​...

The MYMP Has Landed!

Dr. Dvanajscak, Dr. Cassol, MYMP, renal pathology research, arkana laboratories
The MYMP is making its way around Arkana! Dr. Dvanajscak and Dr. Cassol have both released publications this month! Dr. Dvanajscak, along with Dr. Murphy and Dr. Larsen, published a paper regarding Anti-Brush Border Antibody Disease. Dr. Cassol, with Dr. Bourne and Dr. Larsen, published a paper discussing Covid-19 negative renal biopsies. Read the paper: Anti-Brush Border Antibody Disease (Anti-LRP2 Nephropathy) Associated with Lupus Nephritis Read the paper: Appearances can be deceiving - viral-like inclusions in COVID-19 negative renal biopsies by electron microscopy Be on the lookout for the next landing of the MYMP!